T. Rowe Price Associates’s ReposiTrak TRAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$609K Buy
67,580
+17,186
+34% +$157K ﹤0.01% 2530
2026
Q1
$383K Buy
50,394
+22,300
+79% +$214K ﹤0.01% 2561
2025
Q4
$348K Buy
28,094
+5,400
+24% +$76.7K ﹤0.01% 2569
2025
Q3
$337K Buy
22,694
+608
+3% +$10.5K ﹤0.01% 2549
2025
Q2
$434K Sell
22,086
-439
-2% -$9.2K ﹤0.01% 2367
2025
Q1
$457K Buy
22,525
+875
+4% +$18.1K ﹤0.01% 2282
2024
Q4
$480K Buy
21,650
+3,809
+21% +$80.6K ﹤0.01% 2304
2024
Q3
$330K Sell
17,841
-5,926
-25% -$108K ﹤0.01% 2434
2024
Q2
$364K Buy
23,767
+5,767
+32% +$92.9K ﹤0.01% 2323
2024
Q1
$286K Hold
18,000
﹤0.01% 2455
2023
Q4
$181K Buy
18,000
+6,500
+57% +$63.8K ﹤0.01% 2577
2023
Q3
$101K Buy
+11,500
New +$106K ﹤0.01% 2670

Other funds holding TRAK

T. Rowe Price Associates's TRAK Position: Q2 2026 in Review

T. Rowe Price Associates increased its ReposiTrak (TRAK) stake by 34% in Q2 2026, buying an estimated $157K and bringing the position to 67,580 shares worth $609K. The position accounts for ﹤0.01% of the portfolio, ranked #2530.

T. Rowe Price Associates first reported a position in TRAK in Q3 2023 and has held it in 12 quarters since. 116 funds tracked by Wall St. Rank hold TRAK as of Q2 2026.

  • T. Rowe Price Associates held 67,580 shares of ReposiTrak worth $609K as of Q2 2026.
  • T. Rowe Price Associates bought 17,186 ReposiTrak shares in Q2 2026, an estimated $157K.
  • ReposiTrak made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #2530 holding.
  • T. Rowe Price Associates first reported a position in ReposiTrak in Q3 2023 and has held it in 12 quarters since.
  • 116 funds tracked by Wall St. Rank held ReposiTrak as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.